ORBIMED ADVISORS LLC - 31 Dec 2024 SCHEDULE 13D/A Report for Traws Pharma, Inc. Common Stock (TRAW)

Filing Manager
ORBIMED ADVISORS LLC
Reporting Manager
ORBIMED ADVISORS LLC
Symbol
TRAW
Shares outstanding
3,823,236 shares
Disclosed Ownership
760,824 shares
Ownership
20%
Form type
SCHEDULE 13D/A
Filing time
29 Jan 2025, 18:42:44 UTC
Date of event
31 Dec 2024

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ORBIMED ADVISORS LLC 20% 760,824 0 760,824 /s/ Carl L. Gordon Carl L. Gordon/Member 0001055951
OrbiMed Capital GP VIII LLC 20% 760,824 0 760,824 /s/ Carl L. Gordon Carl L. Gordon/Member of OrbiMed Advisors LLC 0001845804